Immunotherapy boosts survival in Tough-to-Treat mesothelioma
NCT ID NCT04334759
First seen Jan 04, 2026 · Last updated Apr 25, 2026 · Updated 14 times
Summary
This study tested whether adding the immunotherapy drug durvalumab to standard chemotherapy helps people with advanced pleural mesothelioma live longer. 214 adults with inoperable tumors received either the combo or standard treatment. Results showed that adding durvalumab improved overall survival, offering a new option for this rare cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALIGNANT PLEURAL MESOTHELIOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Abramson Cancer Cener at Penn Presbyterian Medical Center
Philadelphia, Pennsylvania, 19104, United States
-
Allegheny Cancer Center
Pittsburgh, Pennsylvania, 15224, United States
-
Auckland City Hospital
Grafton, Auckland, 1023, New Zealand
-
Austin Hospital
Heidelberg, Victoria, 3084, Australia
-
Baylor College of Medicine
Houston, Texas, 77030, United States
-
Blacktown Hospital
Blacktown, New South Wales, 2148, Australia
-
Calvary Mater Newcastle
Waratah, New South Wales, 2298, Australia
-
Canberra Hospital
Garran, Australian Capital Territory, 2605, Australia
-
Chris O'Brien Lifehouse
Camperdown, New South Wales, 2050, Australia
-
Cleveland Clinic Foundation
Cleveland, Ohio, 44195, United States
-
Coffs Harbour Health Campus
Coffs Harbour, New South Wales, 2450, Australia
-
Dana Farber Cancer Institute
Boston, Massachusetts, 02215, United States
-
Emory University
Atlanta, Georgia, 30322, United States
-
Epworth HealthCare - Richmond
Richmond, Victoria, 3121, Australia
-
Flinders Medical Centre
Bedford Park, South Australia, 5042, Australia
-
Gosford Hospital
Gosford, New South Wales, 2250, Australia
-
Goulburn Valley Health
Shepparton, Victoria, 3630, Australia
-
Icon Cancer Care Chermside
Chermside, Queensland, 4032, Australia
-
Icon Cancer Care South Brisbane
South Brisbane, Queensland, 4101, Australia
-
Icon Cancer Care Wesley
Auchenflower, Queensland, 4066, Australia
-
Jersey Shore University Medical Center
Neptune City, New Jersey, 07753, United States
-
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Baltimore, Maryland, 21287, United States
-
Launceston General Hospital
Launceston, Tasmania, 7250, Australia
-
Liverpool Hospital
Liverpool, New South Wales, 2170, Australia
-
MD Anderson Cancer Center
Houston, Texas, 77030, United States
-
Massaschusetts General Hospital
Boston, Massachusetts, 02114, United States
-
Memorial Sloan Kettering
New York, New York, 10065, United States
-
Metro Minnesota Community Oncology Research Consortium
Saint Louis Park, Minnesota, 55416, United States
-
Moffitt Cancer Center
Tampa, Florida, 18054, United States
-
Monash Health
Clayton, Victoria, 3168, Australia
-
Morristown Medical/Atlantic Health
Morristown, New Jersey, 07960, United States
-
Nepean Hospital
Kingswood, New South Wales, 2747, Australia
-
NorthShore University Health System/Kellogg Cancer Center
Evanston, Illinois, 60201, United States
-
Northern Cancer Institute (GenesisCare)
Saint Leonards, New South Wales, 2065, Australia
-
Orange Health Service
Orange, New South Wales, 2800, Australia
-
Peninsula & South Eastern Haematology and Oncology Group
Frankston, Victoria, 3199, Australia
-
Penn State Cancer Institute
Hershey, Pennsylvania, 17033, United States
-
Peter MacCallum Cancer Centre
Melbourne, Victoria, 3000, Australia
-
Princess Alexandra Hospital
Woolloongabba, Queensland, 4102, Australia
-
Royal Hobart Hospital
Hobart, Tasmania, 7000, Australia
-
Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey, 08903, United States
-
Sir Charles Gairdner Hospital (SCGH)
Nedlands, Western Australia, 6009, Australia
-
Sunshine Coast University Hospital
Birtinya, Queensland, 4575, Australia
-
Sunshine Hospital (Western Health)
Saint Albans, Victoria, 3021, Australia
-
The Ohio State University
Columbus, Ohio, 43210, United States
-
The Prince Charles Hospital
Chermside, Queensland, 4032, Australia
-
The Queen Elizabeth Hospital
Woodville South, South Australia, 5011, Australia
-
Townsville University Hospital
Douglas, Queensland, 4814, Australia
-
University of California San Diego
La Jolla, California, 92093, United States
-
University of Chicago
Chicago, Illinois, 60637, United States
-
University of Cincinnati
Cincinnati, Ohio, 45267, United States
-
University of Miami
Miami, Florida, 33136, United States
-
University of Michigan
Ann Arbor, Michigan, 48109, United States
-
University of Texas Southwestern Medical Center
Dallas, Texas, 75390, United States
-
University of Virginia
Charlottesville, Virginia, 22903, United States
-
Westmead Hospital
Westmead, New South Wales, 2145, Australia
-
Wyong Hospital
Hamlyn Terrace, New South Wales, 2259, Australia
Conditions
Explore the condition pages connected to this study.